Alterations of FGFR1 have been described in the form of somatic mutations, gene fusions, and intragenic tyrosine kinase domain (TKD) duplications both in pediatric low-grade gliomas and glioblastomas [11, 25, 32]. This evidence concerns the gene FGFR1 and low grade glioma.